- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02676505
Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes (RCT)
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.
Ethical approval obtained and an informed consent will be taken from each patient after explaining the nature and scope of the study.
Methodology in details:
Careful and detailed history taking regarding:
- Personal history
- Complaint.
- History of present pregnancy.
- Menstrual History.
- Past history.
- Careful general examination.
- Abdominal examination.
- Local vaginal examination.
- Ultrasound examination.
Management of Cases:
Group (I)(Coached group):
It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.
Group (II)(Uncoached group):
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .
Patients admitted early in labor are subjected to active management of labor as follows:
Pelvic examination performed. Routine amniotomy performed and progress assessed. When dilatation is not increasing, a low dose protocol of oxytocin infusion will be started. Oxytocin diluted in the form of 5IU in 500 ml Ringer lactate making a concentration of nearly 1mu oxytocin/1ml Ringer solution. Infusion instituted at a rate of 1 -2 milliunit (15-30 drops) per minute and increased gradually in increments of 1 -2 milliunit per minute at 30 minutes interval, until at least three uterine contractions noted in a 10 minute period using cardio tocograph.
Assessment of each stage of labor was performed as follow:
First stage of labor:
It includes:
- Duration of the first stage of labor.
- Rate of cervical dilatation and foetal descent.
- Adequacy of uterine contractions and documentation of labor dystocia.
- Excess uterine activity consisted of uterine tachysystole, hypertonus or uterine hyperstimulation
Second stage of labor:
It includes:
- Duration of the second stage.
- Rate of the descent of foetus.
- Monitoring of foetal heart rate every 5 minutes by sonicaid or continuous by CTG.
- Use of mediolateral episiotomy.
- Intervention will be considered either by instrumental delivery,fundal pressure or by CS If the second stage is prolonged more than 2 hours.
- Monitoring of maternal oxygen saturation by pulse oximeter.
Third stage of labor:
- Duration of the third stage.
- Assessment of any vaginal laceration or perineal tears with their repair as well as repair of episiotomy.
- Assessment of quantity of blood loss and assessment of uterine atony(vital instability,number of soaked pads and hemoglobin drop) .
- Rate of caesarean section during varying stages of labor.
- Neonatal assessment:
It includes:
- Foetal sex and body weight.
- APGAR score at 1 and 5 minutes..
Studietype
Inschrijving (Verwacht)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
All patients admitted in the first stage of labor with cervical dilatation of 4 cm at least:
- Women age 18-35 years.
- 37-41 weeks gestation pregnancy.
- Singleton pregnancy and vertex presentation.
- Women have no chronic or pregnancy-induced illnesses.
- Women are in established, spontaneous labor.
Exclusion Criteria:
- Malpresentation.
- Women with previous uterine scar.
- Multiple pregnancy
- Ante partum hemorrhage.
- Cephalopelvic disproportion.
- Women have chronic illnesses.
- Women with abnormal antenatal period.
- Patients with foetal distress
- Premature rupture of membrane
- Woman having any contraindication to vaginal delivery.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Case-control
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
1
Group (I)(Coached group): It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds. |
It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward.
They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth.
The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.
|
|
2
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth.
|
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Duration of the second stage
Tijdsspanne: 0-3 hours
|
0-3 hours
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Severe maternal morbidity e.g post partum hemorrhage
Tijdsspanne: intrapartum and 2 hours postpartum.
|
intrapartum and 2 hours postpartum.
|
|
APGAR score after one and five minutes.
Tijdsspanne: 1-5 minutes
|
1-5 minutes
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Kasr El Ainy, hospital, kasr el ainy street,cairo,egypt
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- KasrELAini maternity hospital
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .